May 6, 2022

Real estate income opportunity, 8% annualised dividend at 31 March 2022

Real Estate Credit Investments Ltd (LON:RECI) has announced that the Investment Manager’s Q4 Investor Presentation is now available on the Company’s website at: An extract from the Summary section of..

Goodbody Health signing up pharmacies as fast as they can (VIDEO)

Goodbody Health Inc. (CSE: GBDY / AQSE: GBDY / FRA: 484 / OTC: SCNNF) CEO Marc Howells joins DirectorsTalk Interviews to update us on company progress after filing its financial..

Ocado Group to host modelling seminar

Ocado Group plc (LON:OCDO) will be hosting a meeting to discuss modelling of Ocado Group and the underlying operating segments on Wednesday 25th May 2022 at 3pm. Stephen Daintith, CFO,..

DG Innovate appoints Moore Kingston Smith as auditor to the company

DG Innovate plc (LON:DGI) has announced the appointment of Moore Kingston Smith LLP as auditor to the Company. The appointment of Moore Kingston Smith will be subject to approval by..

Revolution Beauty “a remarkably resilient performance” says Zeus

Revolution Beauty Group plc (LON:REVB) has announced full year numbers broadly in line with our forecasts, driven by a record Q4. This is a commendable performance that highlights the resilience..

Ilika Goliath scale-up should be an exciting prospect for shareholders (Analyst VIDEO)

Ilika plc (LON:IKA) is the topic of conversation when Clean-tech Equities Specialist at Baden Hill, Dr Tom McColm joins DirectorsTalk. Tom discusses the successful conclusion of Ilika’s scale-up study, SOLSTICE,..

Analyst corner – Expert insight into Cerillion, Dialight, Symphony Environmental, Surface Transforms and CyanConnode

In Analysts’ corner, DirectorsTalk brings you exclusive professional opinions from five of the leading equity research analysts on five companies listed on the London Stock Exchange. Symphony Environmental Technologies plc (LON:SYM)..

Redde Northgate buy back own shares

Redde Northgate plc (LON:REDD) have today announced that on the 5th May 2022 it purchased the following number of its own shares to be held in treasury: Class of shares..

Cizzle Biotechnology strategic alliance to develop and market early lung cancer detection in USA

Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics developer, has announced that it has signed a heads of terms to partner with CorePath Laboratories, a full service cancer reference..

Search

Funds

May 6, 2022

Search

Funds

May 6, 2022

FTSE 100

Funds